Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis.

Wuerfel J, Sinnecker T, Ringelstein EB, Jarius S, Schwindt W, Niendorf T, Paul F, Kleffner I, Dörr J.

Mult Scler. 2012 Nov;18(11):1592-9. doi: 10.1177/1352458512441270. Epub 2012 Jun 18.

PMID:
22711711
2.

Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.

Sinnecker T, Mittelstaedt P, Dörr J, Pfueller CF, Harms L, Niendorf T, Paul F, Wuerfel J.

Arch Neurol. 2012 Jun;69(6):739-45. doi: 10.1001/archneurol.2011.2450.

PMID:
22351849
3.

A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.

Pelletier J, Suchet L, Witjas T, Habib M, Guttmann CR, Salamon G, Lyon-Caen O, Chérif AA.

Arch Neurol. 2001 Jan;58(1):105-11.

PMID:
11176943
4.

3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS.

Amann M, Achtnichts L, Hirsch JG, Naegelin Y, Gregori J, Weier K, Thöni A, Mueller-Lenke N, Radue EW, Günther M, Kappos L, Gass A.

Mult Scler. 2012 Nov;18(11):1570-6. doi: 10.1177/1352458512441984. Epub 2012 Mar 30.

PMID:
22466702
5.

Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.

van Walderveen MA, Lycklama A Nijeholt GJ, Adèr HJ, Jongen PJ, Polman CH, Castelijns JA, Barkhof F.

Arch Neurol. 2001 Jan;58(1):76-81.

PMID:
11176939
6.

Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.

Bakshi R, Neema M, Healy BC, Liptak Z, Betensky RA, Buckle GJ, Gauthier SA, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ, Guttmann CR, Weiner HL.

Arch Neurol. 2008 Nov;65(11):1449-53. doi: 10.1001/archneur.65.11.1449.

7.

Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.

Zivadinov R, Schirda C, Dwyer MG, Haacke ME, Weinstock-Guttman B, Menegatti E, Heininen-Brown M, Magnano C, Malagoni AM, Wack DS, Hojnacki D, Kennedy C, Carl E, Bergsland N, Hussein S, Poloni G, Bartolomei I, Salvi F, Zamboni P.

Int Angiol. 2010 Apr;29(2):158-75.

PMID:
20351672
8.

Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.

Filli L, Hofstetter L, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Kappos L, Gass A, Sprenger T, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, Bendfeldt K.

Mult Scler. 2012 Nov;18(11):1577-84. doi: 10.1177/1352458512442756. Epub 2012 Apr 11.

PMID:
22495945
9.

White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.

Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, Gaser C, Berthele A, Hoshi M, Jochim A, Kronsbein H, Zimmer C, Hemmer B, Ilg R.

Mult Scler. 2013 Oct;19(11):1485-92. doi: 10.1177/1352458513478673. Epub 2013 Mar 5.

PMID:
23462349
10.

Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis.

Wybrecht D, Reuter F, Zaaraoui W, Faivre A, Crespy L, Rico A, Malikova I, Confort-Gouny S, Soulier E, Cozzone PJ, Pelletier J, Ranjeva JP, Audoin B.

Mult Scler. 2012 Nov;18(11):1585-91. doi: 10.1177/1352458512442991. Epub 2012 Mar 27.

PMID:
22454097
11.

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

Paolillo A, Pozzilli C, Gasperini C, Giugni E, Mainero C, Giuliani S, Tomassini V, Millefiorini E, Bastianello S.

J Neurol Sci. 2000 Mar 15;174(2):85-91.

PMID:
10727693
12.

Susac syndrome. A differential diagnosis for demyelination.

Vattoth S, Compton CJ, Roberson GH, Vaphiades MS.

Neurosciences (Riyadh). 2013 Jan;18(1):74-8.

PMID:
23291802
13.

Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS.

Brandt AU, Zimmermann H, Kaufhold F, Promesberger J, Schippling S, Finis D, Aktas O, Geis C, Ringelstein M, Ringelstein EB, Hartung HP, Paul F, Kleffner I, Dörr J.

PLoS One. 2012;7(6):e38741. doi: 10.1371/journal.pone.0038741. Epub 2012 Jun 11.

14.

T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.

Thaler C, Faizy T, Sedlacik J, Holst B, Stellmann JP, Young KL, Heesen C, Fiehler J, Siemonsen S.

PLoS One. 2015 Dec 11;10(12):e0144693. doi: 10.1371/journal.pone.0144693. eCollection 2015.

15.

Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.

Sinnecker T, Dörr J, Pfueller CF, Harms L, Ruprecht K, Jarius S, Brück W, Niendorf T, Wuerfel J, Paul F.

Neurology. 2012 Aug 14;79(7):708-14. doi: 10.1212/WNL.0b013e3182648bc8. Epub 2012 Aug 1.

PMID:
22855861
18.

Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.

Giorgio A, Stromillo ML, Bartolozzi ML, Rossi F, Battaglini M, De Leucio A, Guidi L, Maritato P, Portaccio E, Sormani MP, Amato MP, De Stefano N.

Mult Scler. 2014 Feb;20(2):214-9. doi: 10.1177/1352458513494490. Epub 2013 Jul 22.

PMID:
23877971
19.

Corpus callosum index and long-term disability in multiple sclerosis patients.

Yaldizli O, Atefy R, Gass A, Sturm D, Glassl S, Tettenborn B, Putzki N.

J Neurol. 2010 Aug;257(8):1256-64. doi: 10.1007/s00415-010-5503-x. Epub 2010 Mar 3.

PMID:
20198382
20.

Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.

Oreja-Guevara C, Rovaris M, Iannucci G, Valsasina P, Caputo D, Cavarretta R, Sormani MP, Ferrante P, Comi G, Filippi M.

Arch Neurol. 2005 Apr;62(4):578-84.

PMID:
15824256

Supplemental Content

Support Center